Pubblicazioni del dott. alfredo pece dal 2008 al 2011

Pece A, Milani P, Isola V, Pierro L.
A long-term study of photodynamic therapy with verteporfin for choroidal neovascularization at the edge of chorioretinal atrophy in pathologic myopia.
Ophthalmologica. 2011;225(3):161-8.

Querques G, Berboucha E, Leveziel N, Pece A, Souied EH.
Preferential hyperacuity perimeter in assessing responsiveness to ranibizumab therapy for exudative age-related macular degeneration.
Br J Ophthalmol. 2011 Jul;95(7):986-91.

Milani P, Pece A, Pierro L, Seidenari P, Radice P, Scialdone A.
Bevacizumab for macular serous neuroretinal detachment in tilted disk syndrome.
J Ophthalmol. 2010;2010:970580.

Vadalà M, Pece A, Cipolla S, Monteleone C, Fasolino G, Casuccio A, Cillino S
Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study.
Br J Ophthalmol. 2011 May;95(5):657-61.

Pece A, Querques G, Quinto A, Isola V.
Intravitreal ranibizumab injection for nonarteritic ischemic optic neuropathy.
J Ocul Pharmacol Ther. 2010 Oct;26(5):523-7.

Pece A, Isola V, Piermarocchi S, Calori G.
Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up.
Br J Ophthalmol. 2011 Jan;95(1):56-68.

Pece A, Russo G, Ricci F, Isola V, Introini U, Querques G.
Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks.
Clin Ophthalmol. 2010 Jun 24;4:525-30.

Vadalà M, Pece A, Cipolla S, Monteleone C, Ricci F, Boscia F, Cillino S.
Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab.
Retina. 2010 Jun;30(6):903-7.

Chan WM, Lim TH, Pece A, Silva R, Yoshimura N.
Verteporfin PDT for non-standard indications--a review of current literature.
Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):613-26.

Querques G, Azrya S, Martinelli D, Berboucha E, Feldman A, Pece A, Coscas G, Soubrane G, Souied EH.
Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting.
Br J Ophthalmol. 2010 Mar;94(3):292-6. Epub 2009 Dec 1.

Pece A, Isola V, Holz F, Milani P, Brancato R.
Autofluorescence imaging of cystoid macular edema in diabetic retinopathy.
Ophthalmologica. 2010;224(4):230-5.

Pece A, Vitale L, Milani P, Pierro L.
Spontaneous reattachment of the margins of a macular retinal pigment epithelium tear: optical coherence tomography documentation of a case.
Ophthalmologica. 2010;224(3):159-61.

Milani P, Pece A, Moretti G, Lino P, Scialdone A.
Intravitreal bevacizumab for CNV-complicated tilted disk syndrome.
Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1179-82.

Le terapie intravitreali. Monografia. Quaderni di oftalmologia editore SOI, Società Oftalmologia Italiana 2008. Farmaci intravitrealiantiangionetici.

Pece A, Isola V.
Retinal pigment epithelial marginal retraction after photodynamic therapy for choroidal neovascularization in pathologic myopia.
Eur J Ophthalmol. 2008 Sep-Oct;18(5):841-4.

Cattaneo Z, Bhatt E, Merabet LB, Pece A, Vecchi T.
The influence of reduced visual acuity on age-related decline in spatial working memory: an investigation.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2008 Nov;15(6):687-702.

Parodi MB, Iacono P, Pedio M, Pece A, Isola V, Fachin A, Pinto M, Ravalico G.
Autofluorescence in adult-onset foveomacular vitelliform dystrophy.
Retina. 2008 Jun;28(6):801-7.

Pece A, Isola V, Vitale L.
Management of choroidal neovascularization in myopic macular degeneration.
Expert Rev. Ophthalmol, 2008, 3 (3),311-323.

Pece A.
Ranibizumab nelle CNV occulte. In Terapia anti-angiogenetica in oftalmologia -Casi clinici. A cura prof P.Lanzetta. Elleboro Ed.2008